CORRECTION article

Front. Cell. Infect. Microbiol., 10 February 2022

Sec. Clinical and Diagnostic Microbiology and Immunology

Volume 12 - 2022 | https://doi.org/10.3389/fcimb.2022.843577

Corrigendum: Effects of Zinc Oxide Nanoparticles Synthesized Using Aspergillus niger on Carbapenem-Resistant Klebsiella pneumonia In Vitro and In Vivo

  • 1. Department of Botany and Microbiology, College of Science, King Saud University, Riyadh, Saudi Arabia

  • 2. Department of Zoology, College of Science, King Saud University, Riyadh, Saudi Arabia

  • 3. College of Science, King Saud University, Riyadh, Saudi Arabia

  • 4. Department of Medicine, Vascular Biology Center, Medical College of Georgia at Augusta University, Augusta, GA, United States

Article metrics

View details

1,3k

Views

531

Downloads

Incorrect Affiliation

In the published article, there was an error in affiliation 3. Instead of “King Abdullah Institute of Nanotechnology, King Saud University, Riyadh, Saudi Arabia”, it should be “College of Science, King Saud University, Riyadh, Saudi Arabia”.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher’s Note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Summary

Keywords

zinc oxide nanoparticle, antimicrobial resistance, biological synthesis, carbapenem-resistant Klebsiella pneumoniae (KPC), Aspergillus niger, wound recovery

Citation

Rasha E, Alkhulaifi MM, AlOthman M, Khalid I, Doaa E, Alaa K, Awad MA and Abdalla M (2022) Corrigendum: Effects of Zinc Oxide Nanoparticles Synthesized Using Aspergillus niger on Carbapenem-Resistant Klebsiella pneumonia In Vitro and In Vivo. Front. Cell. Infect. Microbiol. 12:843577. doi: 10.3389/fcimb.2022.843577

Received

26 December 2021

Accepted

21 January 2022

Published

10 February 2022

Approved by

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Volume

12 - 2022

Updates

Copyright

*Correspondence: Elsayim Rasha, ; Mohnad Abdalla,

This article was submitted to Clinical Microbiology, a section of the journal Frontiers in Cellular and Infection Microbiology

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Outline

Cite article

Copy to clipboard


Export citation file


Share article

Article metrics